NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ENLITIC INC. (ENL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of ENL: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

MUFG Corporate Markets Limited (was Link Market Services)
Liberty Place Level 41 161 Castlereagh St Sydney NSW 2000 Locked Bag A14 Sydney South NSW 1235
Tel : 1300 554 474
Fax : (02) 9287 0303 or (02) 9287 0309 (for voting)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000305427
Address: c/o Company Matters Pty Ltd Liberty Place, Level 41, 161 Castlereagh Street Sydney NSW 2000 Australia
Tel:  (+1) 970-657-9218

Date first listed: 19/12/2023

Sector: Health Care Equipment & Services 
Activities: Enlitic is a software development company that uses artificial intelligence to develop software products that manage medical imaging data in radiology (such as MRI, CT, X-ray and ultrasound images) and licences such products to healthcare providers

News & Events

Expand this box to read and print

The suspension of trading in the securities of Enlitic Inc. will be lifted immediately following the release by ENL of an announcement regarding an equity raise.

05/05/2025

The company has signed a binding MOU with GE HealthCare. The agreement requires Laitek to deliver 3-6m per year of annual migration capacity to GE HealthCare, with GE HealthCare prepaying $2m for Laitek's migration services. Enlitic has also secured A$10m in funding through a two-tranche placement via new CDIs.

05/05/2025

The company's securities will be suspended from quotation under Listing Rule 17.3.2 to prevent a disorderly or uninformed market. ASX halted trading in ENL's securities on 5 May 2025 under ASX Operating Rule 3100 to ensure fairness and transparency. ENL provided a non-sensitive announcement to ASX, and ENL's securities will remain suspended until it is released.

05/05/2025

listed entity carried for record purposes only

19/12/2023

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Lawrence GozlanChairman19/12/2023
    Lisa PettigrewIndependent Director04/03/2024
    Michael SistenichDirector, CEO19/12/2023
    Sergio DuchiniDirector13/12/2023
    Darren ScottiCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Riichi YamadaNon Exec Director19/12/202331/12/2024

    Date of first appointment, title may have changed.